Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 4, 2024 22:03 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 697 | $16.75 | $11,674.75 |
DisclosureSEC source: 0001628280-24-000468 · wk-form4_1704405819.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,765 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 22, 2023 Filed Dec 28, 2023 21:46 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 314 | $16.79 | $5,272.06 |
DisclosureSEC source: 0001628280-23-042810 · wk-form4_1703800002.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,339 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 17, 2023 Filed Dec 19, 2023 22:54 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 254 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042031 · wk-form4_1703026481.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,366 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 17, 2023 Filed Dec 19, 2023 22:55 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 705 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042032 · wk-form4_1703026496.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,666 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 17, 2023 Filed Dec 19, 2023 22:54 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042030 · wk-form4_1703026465.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,568 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 17, 2023 Filed Dec 19, 2023 22:54 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042029 · wk-form4_1703026451.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,798 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 03, 2023 Filed Dec 21, 2023 20:44 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 258 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042481 · wk-form4_1703191474.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,826 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 03, 2023 Filed Dec 21, 2023 20:44 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 287 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042480 · wk-form4_1703191464.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,653 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 03, 2023 Filed Dec 21, 2023 20:44 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042479 · wk-form4_1703191454.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,027 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 03, 2023 Filed Dec 21, 2023 20:44 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-042478 · wk-form4_1703191443.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,462 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 00:15 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 466 | $12.37 | $5,764.42 |
DisclosureSEC source: 0001628280-23-040677 · wk-form4_1701735316.xml · nonDerivative · entry 2 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,340 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 00:15 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 394 | $12.37 | $4,873.78 |
DisclosureSEC source: 0001628280-23-040676 · wk-form4_1701735302.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,062 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 591 | $12.37 | $7,310.67 |
DisclosureSEC source: 0001628280-23-040675 · wk-form4_1701735287.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,961 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 00:14 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 303 | $12.37 | $3,748.11 |
DisclosureSEC source: 0001628280-23-040674 · wk-form4_1701735274.xml · nonDerivative · entry 2 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,587 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 00:14 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 394 | $12.37 | $4,873.78 |
DisclosureSEC source: 0001628280-23-040673 · wk-form4_1701735258.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,522 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 00:14 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 666 | $12.37 | $8,238.42 |
DisclosureSEC source: 0001628280-23-040672 · wk-form4_1701735246.xml · nonDerivative · entry 2 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,112 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 19, 2023 Filed Dec 5, 2023 00:15 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 267 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-040677 · wk-form4_1701735316.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,806 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 19, 2023 Filed Dec 5, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-040675 · wk-form4_1701735287.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,552 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 19, 2023 Filed Dec 5, 2023 00:14 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 234 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-040674 · wk-form4_1701735274.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,890 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 19, 2023 Filed Dec 5, 2023 00:14 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 298 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-040672 · wk-form4_1701735246.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,778 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 15:41 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 114 | $10.77 | $1,227.78 |
DisclosureSEC source: 0001628280-23-039100 · wk-form4_1700062902.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,539 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 15:41 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 76 | $10.77 | $818.52 |
DisclosureSEC source: 0001628280-23-039099 · wk-form4_1700062891.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,456 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 15:41 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 98 | $10.77 | $1,055.46 |
DisclosureSEC source: 0001628280-23-039098 · wk-form4_1700062879.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,916 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 15:41 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 111 | $10.66 | $1,183.26 |
DisclosureSEC source: 0001628280-23-039097 · wk-form4_1700062865.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,656 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 15:41 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 132 | $10.77 | $1,421.64 |
DisclosureSEC source: 0001628280-23-039096 · wk-form4_1700062853.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,726 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 15:40 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 97 | $10.66 | $1,034.02 |
DisclosureSEC source: 0001628280-23-039095 · wk-form4_1700062841.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,480 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| November 05, 2023 Filed Nov 13, 2023 21:41 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 299 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-038654 · wk-form4_1699911667.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,653 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 05, 2023 Filed Nov 13, 2023 21:41 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 262 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-038653 · wk-form4_1699911654.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,767 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 05, 2023 Filed Nov 13, 2023 21:40 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-038652 · wk-form4_1699911624.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,577 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 05, 2023 Filed Nov 13, 2023 21:40 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-038651 · wk-form4_1699911598.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,858 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:10 UTC |
Schick Joseph CDirector
|
GrantCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036782 · wk-form4_1699045830.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,689 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:10 UTC |
GOSWAMI JOYDEEPDirector
|
GrantCommon Stock | 577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036781 · wk-form4_1699045814.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,846 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:10 UTC |
Ellingson RachelDirector
|
GrantCommon Stock | 495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036780 · wk-form4_1699045799.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,685 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:09 UTC |
DuRoss AmyDirector
|
GrantCommon Stock | 598 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036779 · wk-form4_1699045788.xml · nonDerivative · entry 1 DuRoss Amy · CIK 0001854968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,379 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:09 UTC |
MOORE TIMOTHY L.Director
|
GrantCommon Stock | 495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036778 · wk-form4_1699045777.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,633 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 30, 2023 Filed Nov 1, 2023 21:30 UTC |
Rice MichaelFormer CEO and Director
|
SaleCommon Stock | 72,603 | $9.13 | $662,865.39 |
DisclosureSEC source: 0001628280-23-036053 · wk-form4_1698874195.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Former CEO and Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 347,085 F1 · kind: The sale reported herein was made pursuant to Rule 10b5-1 (c) trading plans adopted by the reporting person effective as of 03-25-2020, 02-08-21, 02-24-2022, and 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| October 22, 2023 Filed Oct 24, 2023 23:45 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-035028 · wk-form4_1698191134.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,505 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 22, 2023 Filed Oct 24, 2023 23:46 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 335 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-035029 · wk-form4_1698191164.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,354 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 22, 2023 Filed Oct 24, 2023 23:45 UTC |
Rice MichaelFormer CEO and Director
|
GrantCommon Stock | 771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-035027 · wk-form4_1698191120.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Former CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,688 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 22, 2023 Filed Oct 24, 2023 23:45 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 1,034 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-035026 · wk-form4_1698191102.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,934 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 22, 2023 Filed Oct 24, 2023 23:44 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-035025 · wk-form4_1698191090.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,244 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 19, 2023 Filed Oct 23, 2023 21:42 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 927,165 | $11.19 | $10,374,976.35 |
DisclosureSEC source: 0000919574-23-005783 · ownership.xml · nonDerivative · entry 1 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,557,165 F1 · ownership.direct: The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| October 19, 2023 Filed Nov 1, 2023 21:29 UTC |
DE GREEF RODERICKDirector · President and CEO
|
GrantRestricted Stock Award · Derivative | 394,856 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-036052 · wk-form4_1698874183.xml · derivative · entry 2 DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,856 Underlying: Common Stock · 394,856 shares Expires not disclosed F3 · shares: The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027. F3 · derivative.exercise_date: The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027. F3 · derivative.expiration_date: The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027. Read SEC document |
| October 19, 2023 Filed Nov 1, 2023 21:29 UTC |
DE GREEF RODERICKDirector · President and CEO
|
GrantCommon Stock | 394,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036052 · wk-form4_1698874183.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,539 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of their employment agreement. F2 · balance_after: This reflects the total amount beneficially owned by the reporting person as of October 19, 2023. Previous Form 4's filed by the reporting person before October 19, 2023 did not reflect the acquisition of 2,421 shares. Read SEC document |
| October 19, 2023 Filed Nov 1, 2023 21:29 UTC |
Richardson GarrieChief Revenue Officer
|
GrantCommon Stock | 36,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036051 · wk-form4_1698874172.xml · nonDerivative · entry 1 Richardson Garrie · CIK 0001999183 · Chief Revenue Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,327 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter annually, in 4 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation in connection with their appointment as Chief Revenue Officer. Read SEC document |
| October 08, 2023 Filed Oct 10, 2023 21:26 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034203 · wk-form4_1696973159.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,900 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 08, 2023 Filed Oct 10, 2023 21:25 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034202 · wk-form4_1696973147.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,214 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 08, 2023 Filed Oct 10, 2023 21:25 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 252 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034201 · wk-form4_1696973135.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,019 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 08, 2023 Filed Oct 10, 2023 21:25 UTC |
Rice MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034200 · wk-form4_1696973124.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,917 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| October 08, 2023 Filed Oct 10, 2023 21:25 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034199 · wk-form4_1696973109.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,871 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.